Construct | Measure | Screening | Wave 1 | Intervention Phase | Wave 2 | Wave 3 |
---|---|---|---|---|---|---|
ESM-questionnaire* | Developed for study | X | ||||
Main study parameters | ||||||
Self-harming thoughts and behaviors | Developed for study | X | ||||
Emotion regulation | DERS-18 | X | X | X | ||
Quality of relationships | NRI-BSV | X | X | X | ||
Secondary parameters | ||||||
Evaluation of PRIMARY* | UMUX Modified CSQ-8 | X | ||||
Questions developed for the study | ||||||
Other parameters | ||||||
Demographics | Developed for study | X | ||||
Concomitant treatment | Developed for study | X | X | X | ||
BPD symptoms | SCID-II BPD PQ | X | ||||
BPD behavior | BSL-23 | X | X | X | ||
Achievement of developmental milestones | DML | X | X | X | ||
Life experiences | Modified LES | X | X | |||
Psychopathology | SPSY | X | X | X | ||
Alternative Model for Personality Disorders | LPFS-BF PID-5-BF | X | X | X | ||
Impulsivity | S-UPPS | X | ||||
Internalizing problems | DASS | X | X | X | ||
Loneliness | De Jong Gierveld questionnaire | X | X | X | ||
Motivation for change | MYTS | X | X | X | ||
Quality of life | ReQoL | X | X | X | ||
Impact of COVID-19 | Developed for study | X | X | X |